Following confirmation of increased metastatic ability in hypoxia-treated breast cancer cells, we wished to investigate whether CXCR4 played a role in this increased capacity, as CXCR4 has been implicated in breast cancer metastases and linked to tumours with increased levels of HIF1α (a surrogate of hypoxia). The gene discussed is CXCR4; the disease is neoplasm.